Header Logo

Connection

SANJAY DESHPANDE to Etoposide

Back to Details
This is a "connection" page, showing publications SANJAY DESHPANDE has written about Etoposide.
SANJAY DESHPANDE
Connection Strength
0.051
Etoposide
  1. Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial. Blood Adv. 2023 02 28; 7(4):602-610.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.